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Abstract: We obtained data on smoking by parents from 438
cancer cases and 470 controls to investigate whether cancer risk in
adult life is related to transplacental or childhood exposure to
cigarette smoke. Cancer cases were between ages 15 and 59 at time
of diagnosis. All sites but basal cell cancer of the skin were included.
Cancer risk was increased 50 per cent among offspring of men who
smoked. Increased risk associated with father's smoking was not
explained by demographic factors, social class, or individual smok-
ing habits, and was not limited to known smoking related sites.
Relative risk (RR) estimates associated with father's smoking
Introduction
Cancer risk in adult life may be affected by transplacen-
tal and childhood exposure to cigarette smoke.' Data from
studies in animals have demonstrated that many carcinogens
are active when administered transplacentally or during
early life. In some instances, effects may be produced at
lower doses than are required for adults.2-6 The tumors
resulting from these transplacental and early postnatal expo-
sures may not be apparent until adulthood.3 7-9
Studies in humans demonstrate that the fetus of smok-
ing parents is exposed to components of cigarette smoke and
is capable of bioactivating these chemicals.'0-20 For exam-
ple, cotinine has been measured in the amniotic fluid of
smokers and passive smokers'3 and thiocyanate has been
measured in fetal cord blood.'4-'6 Studies have also demon-
strated increased activity of enzymes that metabolize ben-
zo(a)pyrene in placentas of women who smoke,'7-'9 and
possibly even in placentas of women passively exposed to
cigarette smoke.20 Similar elevations may occur in the
tissues of the fetus or exposed child. Finally, increased
urinary excretion of mutagens has been found in passive
smokers.21
Several epidemiologic studies have demonstrated in-
creased risk for childhood tumors in relation to either
paternal or maternal smoking,22-24 but not all studies demon-
strate an increased risk.25,26 Even if no increased risk of
childhood cancer were found, however, it would not rule out
the possibility of increased cancer risk during adult life from
fetal or childhood exposure. One recent study found elevat-
ed lung cancer risk for individuals whose mothers smoked.27
Cigarette smoke contains many known carcinogens.28
Sidestream smoke, which is the smoke released fromn the
cigarette between active puffs, may differ qualitatively from
the mainstream smoke which is inhaled by the active smok-
er.28 Some compounds occur in markedly higher concentra-
tions in sidestream smoke, and although this smoke is
diluted by the ambient air into which it is released, the
Address reprint requests to Dale P. Sandler, MPH, PhD, Epidemiology
Branch, Biometry and Risk Assessment Program, National Institute of
Environmental Health Sciences, Mail Drop A3-02, P.O. Box 12233, Research
Triangle Park, NC 27709. Drs. Everson and Wilcox are also with NIEHS; Dr.
Browder is with the Department of Surgery, School of Medicine, University
of North Carolina, Chapel Hill. This paper, submitted to the Journal May 1,
1984, was revised and accepted for publication October 16, 1984.
tended to be greatest for smokers, males, and non-Whites. There
was only a slight increase in overall cancer risk associated with
maternal smoking. Mother's and father's smoking were both associ-
ated with risk for hematopoietic cancers, and a dose-response
relationship was seen. The RR for hematopoietic cancers increased
from 1.7 when one parent smoked to 4.6 when both parents smoked.
Although they should be considered tentative, study findings sug-
gest a long-term hazard from transplacental or childhood passive
exposure to cigarette smoke. (Am J Public Health 1985; 75:487-
492.)
passive smoker may inhale smoke which is qualitatively
richer in certain compounds than mainstream smoke (Hoff-
man in 28). For example, the concentration of dimethylni-
trosamine in sidestream smoke is 52 times that in main-
stream smoke. Such qualitative differences make it difficult
to predict the biologic effect of exposure to sidestream
smoke.
In this study we investigate whether cancer risk in adult
life is related to transplacental or childhood exposure to
cigarette smoke.
Methods
Our study methods have been described in greater detail
elsewhere.29 Cancer cases were selected from the hospital
based tumor registry at the North Carolina Memorial Hospi-
tal of the University of North Carolina in Chapel Hill. They
included all cases diagnosed between July 1, 1979 and March
31, 1981 and assumed to be alive as of March 31, 1981. Cases
were between ages 15 and 59 at time of diagnosis and
included all cancer sites except basal cell cancer of the skin.
Cases were restricted to age 59 and younger, since fewer
than 5 per cent of women of child bearing age in 1920 were
smokers.30'31
Cases were mailed a questionnaire for self completion,
followed by a second mailing and a telephone call if needed.
Of 740 eligible cancer cases identified from the tumor
registry, 107 (14 per cent) died before we could contact
them. An additional 115 (16 per cent) either refused (n = 71)
to participate or could not be contacted. Cases who died or
did not respond were slightly older and were more often
male or non-White; cases with respiratory cancer were more
likely to have been excluded, presumably due to higher case
fatality. In all, completed questionnaires were obtained for
518 (70 per cent) of the eligible cases.
In addition to questions on exposure to cigarette smoke,
cases were asked to identify friends or acquaintances who
did not have cancer and were the same race, sex, and age (±
5 years) to serve as comparison subjects. Approximately 60
per cent of the controls were identified in this manner. For
cases for whom friend controls were not successfully ob-
tained, population controls were identified by systematic
telephone sampling. Data were analyzed separately by con-
trol selection group and the adjusted results were nearly
identical to those obtained when the control groups were
combined.
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Individuals were specifically requested to supply infor-
mation on natural parents. Only individuals who lived with
both natural parents for all or most of the first 10 years of life
are included in this report. As a result, 128 individuals were
excluded (80 cases and 48 controls).
Transplacental and childhood exposure to cigarette
smoke was assessed from questionnaire reports of smoking
histories of parents. Subjects were asked whether parents
ever smoked, smoked before the subject's birth, smoked in
the house for most of the years before the subject was 10
years old, and whether mothers smoked while pregnant with
the study subject. Subjects were also asked the usual quanti-
ty of cigarettes smoked by the parents and the frequency of
smoking in the house. For this report, unless otherwise
specified, exposure is classified by parental smoking in the
household before the subject attained 10 years of age.
For this report, "smoking related" tumors were defined
as cancer of the oral cavity and pharynx, esophagus, pancre-
as, respiratory and intrathoracic organs, urinary tract and
cervix.28 Because evidence linking cervical cancer with
cigarette smoking is not well documented, we also analyzed
these data with cervical cancer excluded from this designa-
tion. The number of "smoking related" tumors was substan-
tially reduced by this exclusion, but the general findings
were not altered. For individual smoking status, smokers are
defined to include anyone who ever smoked at least one
cigarette a day for as long as six months. Nonsmokers are
individuals who have never smoked.
Estimates of the relative risk (RR) in stratified analyses
were obtained using the Mantel-Haenszel technique32 for the
summary odds ratio. The method of Gart33 was used to
obtain 95 per cent confidence limits for the combined
estimates of RR. Estimates of the relative risk adjusted
simultaneously for multiple confounding variables were ob-
tained using a multiple logistic model.
Level of education was reported as number of years of
school completed and occupation was given as usual occupa-
tion. For stratified analyses, age and level of education were
treated as categorical variables with four levels of age (<30,
30-39, 40-49, 50+) and three levels of education (< 12 years,
12 years, >12 years). Age was treated as a continuous
variable in the multiple logistic analysis.
Controls were matched one-to-one to cases to allow the
selection of population controls without having an enumerat-
ed sampling frame. The analyses presented here are un-
matched to maximize the study size following losses due to
missing data on exposure. In most comparisons, the factors
used in control selection are taken into account by adjust-
ment procedures. Analyses using matched pairs gave similar
results.
Results
Cases and controls are distributed similarly by age,
race, and sex (Table 1). Cases and controls differ only in
their distribution by years of schooling with fewer cases
having completed high school. However, cases and controls
are similar in broad occupational categories. Cases and
controls are similar with regard to their own smoking status
with 45 per cent of cases and 47 per cent of controls never
having smoked; the similarity is largely due to the use of
friends as controls. When only cases with population con-
trols are included, 57 per cent of cases and 47 per cent of
population controls were smokers.
Maternal Smoking
There was only a small difference between cases and
controls in reported exposure to maternal smoking [estimat-
ed relative risk (RR) = 1.1, 95 per cent confidence limits =
0.7, 1.6]. The RR for cancer among individuals whose
mothers smoked was close to one for all measures of
maternal smoking, and this lack of association persisted after
adjustment for potential confounding factors including age,
race, sex, education, individual smoking, and method of
control selection.
Site specific relative risk estimates were calculated for
13 different sites, even though for many sites the number of
cases is too small for detailed analysis. For most sites, the
RR in relation to maternal smoking was close to one (Table
2). However, the RR for leukemia and lymphoma was 2.7 (95
per cent confidence limits = 1.3, 5.8). The RR for hemato-
poietic cancers associated with maternal smoking is greater
for individuals whose fathers also smoked (2.6 vs 1.5 for
nonsmoking fathers), but the RR remained elevated (RR =
2.4, 95 per cent confidence limits = 1.0, 5.5) after adjusting
for father's smoking. Adjustment for age, race, sex, educa-
tion, and individual smoking did not change this finding. The
numbers of specific hematopoietic cancers are small pre-
cluding detailed analysis. However, the crude RR for Hodg-
kins disease (RR = 4.4, 95 per cent confidence limits = 1. 1,
4.6), non-Hodgkins lymphomas (RR = 1.7, 95 per cent
confidence limits = 0.5, 5.2) and acute leukemias (RR = 8.8,
95 per cent confidence limits = 2.0, 40.0) were greater than
one.
TABLE 1-Comparisons of Cases and Controls
Cases Controls
Factor N (%) N (%)
Total 438 (100) 470 (100)
Age (years)
<30 83 (19) 89 (19)
30-39 72 (16) 95 (20)
40-49 117 (27) 110 (23)
50-59 166 (38) 176 (37)
Mean Age 43 43
Race
White 325 (74) 340 (72)
Non-White 113 (26) 130 (28)
Sex
Male 147 (34) 158 (34)
Female 291 (66) 312 (66)
Educationt
<12 years 182 (42) 164 (35)
12 years 122 (28) 171 (36)
>12 years 133 (30) 135 (29)
Occupationt
Blue Collar 158 (39) 154 (34)
White Collar 154 (38) 183 (40)
"Housewife" 97 (24) 118 (26)
Smoking Status
Nonsmoker 197 (45) 223 (47)
Smoker 241 (55) 247 (53)
Mother's Smokingt
No 353 (84) 389 (85)
Yes 65 (16) 66 (15)
Father's Smokingt
No 166 (44) 234 (53)
Yes 212 (56) 204 (47)
tNumbers reduced because of missing values.
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TABLE 2-Cancer Risk from Mother's Smoking, All Sites Combined and
Selected Sites
Cases
Crude 95%
Site No. (% exposed)t RR Conf. limits
All Sites 418* (16) 1.1 (0.7, 1.6)
"Smoking Related" 131 (13) 0.9 (0.5, 1.6)
Not "Smoking Related" 287 (17) 1.2 (0.8,1.8)
Lip, Oral Cavity and Pharynx 17 (12) 0.8 (0.2, 3.5)
Digestive System 31 (10) 0.6 (0.2, 2.1)
Respiratory System 22 (14) 0.9 (0.3, 3.2)
Lung 15 (13) 0.9 (0.2, 4.1)
Bone, Skin and Connective
Tissue 36 (8) 0.5 (0.2, 1.8)
Breast$ 53 (15) 0.9 (0.4, 2.1)
Female Genital Tractl 133 (17) 1.1 (0.7, 2.2)
Cervixt 80 (15) 0.9 (0.6, 1.9)
Prostate§ 10 (0) 0.0 (0.0, 3.7)¶
Testis§ 5 (20) 1.8 (0.2, 16.6)
Urinary Tract 6 (0) 0.0 (0.0, 5.1)¶
Eye, Brain and Other
Nervous System 37 (11) 0.7 (0.2, 2.1)
Brain 31 (13) 0.9 (0.3, 2.7)
Endocrine Glands 21 (19) 1.4 (0.5, 4.2)
Hematopoietic Tissue 41 (32) 2.7 (1.3, 5.8)
Other 6 (17) 1.2 (0.1, 10.3)
*Missing values for mother's smoking.
tFor comparison 66 (15%) of 455 controls were exposed to mother's smoking.
*Sex specific comparison: 16% of 301 female controls were exposed.
§Sex specific comparison: 12% of 154 male controls were exposed.
¶Exact confidence limits.
Paternal Smoking
There was an overall relative risk estimate of 1.5 (95 per
cent confidence limits = 1. 1, 2.0) for cancer among individ-
uals whose fathers smoked in the household (Table 3).
Adjusting for potential differences in age, sex, race, individ-
ual smoking status, smoking by spouse, education, maternal
TABLE 3-Cancer Risk from Father's Smoking, All Sites Combined and
Selected Sites
Cases
Crude 95%
Site No. (% exposed)t RR Conf. limits
All Sites 378* (56) 1.5 (1.1,2.0)
"Smoking Related" 120 (58) 1.6 (1.0, 2.5)
Not "Smoking Related" 258 (55) 1.4 (1.0, 1.9)
Lip, Oral Cavity and Pharynx 17 (53) 1.3 (0.4, 3.8)
Digestive System 30 (60) 1.7 (0.8, 3.9)
Respiratory System 22 (50) 1.1 (0.5,2.9)
Lung 13 (62) 1.8 (0.5, 6.6)
Bone, Skin and Connective
Tissue 34 (32) 0.5 (0.2,1.2)
Breastt 51 (51) 1.1 (0.6,2.1)
Female Genital Tractl 113 (60) 1.6 (1.0, 2.6)
Cervixt 70 (61) 1.7 (1.0, 3.0)
Prostate§ 9 (44) 1.0 (0.2, 4.7)
Testis§ 5 (80) 5.2 (0.5, 125.9)
Urinary Tract 5 (40) 0.8 (0.1,5.7)
Eye, Brain and Other
Nervous System 30 (63) 2.0 (0.9, 4.6)
Brain 24 (67) 2.3 (0.9, 6.0)
Endocrine Glands 20 (55) 1.4 (0.5, 3.8)
Hematopoietic Tissue 37 (68) 2.4 (1.1, 5.2)
Other 5 (80) 4.6 (0.5, 108.7)
'Missing values for father's smoking.
tFor comparison 47% of 438 controls were exposed to father's smoking.
*Sex specific comparison: 48% of 288 female controls were exposed.
§Sex specific comparison: 43% of 150 male controls were exposed.
smoking, or method of control selection did not alter this
finding (RR = 1.5). Estimates of the adjusted RR were
obtained separately for the group with friend controls (RR =
1.6) and the group with population controls (RR = 1.4). The
combined adjusted RR in a matched pairs analysis with a
much smaller data set was also similar. The RR for cancer
associated with father's smoking was greater for males than
females (1.7 vs 1.4), for non-Whites than for Whites (1.7 vs
1.4), and for smokers than for nonsmokers (1.7 vs 1.2).
Crude estimates of relative risk for cancers at specific
sites in relation to father's smoking are shown in Table 3.
The RR for "smoking related" (RR = 1.6) and for "not
smoking related" sites (RR = 1.4) are similar. Specific sites
with elevated RR included cervix, brain, and hematopoietic
tissue.
The RR of 1.7 for cervical cancer among individuals
whose fathers smoked is unaffected by adjustment for age,
race, sex, maternal smoking, individual smoking, or spouse
smoking. The two-fold increase in risk for brain tumors in
relation to paternal smoking is similarly unaffected by adjust-
ment for potential confounding variables. Although the
number of lung cancer cases with data on father's smoking is
small (n = 13), the crude RR for lung cancer associated with
father's smoking is 1.8, and is 2.5 after adjusting for age and
individual smoking. The RR remains elevated when smoking
by spouse and mother are also taken into consideration.
Leukemia and lymphoma risk is also not substantially
changed by adjustment for age, sex, race, spouse smoking,
and individual smoking. The adjusted RR is 2.5. However,
the risk is greater for individuals whose mothers also smoked
(RR = 3.1 vs 1.8 for individuals whose mothers did not
smoke) and the RR is 1.9 (95 per cent confidence limits =
0.9, 4.4) after adjusting for maternal smoking. For specific
hematopoietic cancers, the crude RR was elevated for
Hodgkins disease (RR = 5.7, 95 per cent confidence limits =
1.2, 38.4), non-Hodgkins lymphomas (RR = 1.6, 95 per cent
confidence limits = 0.6, 4.3), and for acute leukemias (RR =
4.6, 95 per cent confidence limits = 0.6, 34.2).
Individual Smoking Status
Overall and site specific relative risk estimates are
shown separately for individuals who smoked and those who
never smoked in Table 4. Relative risk estimates in relation
to mother's smoking are similar for smokers and nonsmok-
ers and are close to one for all sites but hematopoietic tissue.
Increased cancer risk related to father's smoking is not
limited to smokers or nonsmokers, although the RR for all
sites combined is greater among smokers.
Dkse-response
The elevated risks for all cancers combined and for most
specific sites were related primarily to father's smoking.
However, for leukemia and lymphoma there is an increase in
risk when both parents smoked. The RR is 1.7 when one
parent smoked and 4.6 if both parents smoked (Mantel-
Haenszel chi for trend = 3.25, p < 0.001). For both mother's
and father's smoking, overall cancer risk increased only
slightly with reported frequency of smoking in the house.
Risk also tended to increase with reported number of ciga-
rettes smoked, but a large proportion of missing values make
these data unreliable.
Discussion
We have found overall cancer risk to be increased
among the offspring of men who smoked. There was only a
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TABLE 4-Cancer Risk from Parental Smoking among Nonsmokers and Smokers, All Sites Combined and Selected Sitest
Maternal moking Paternal moking
Nonsmokers Smokers Nonsmokers Smokers
Site No. (% exposed)t RR No. (% exposed)t RR No. (% exposed)§ RR No. (% exposed)§ RR
All Sites 191 (12) 1.2 227 (19) 1.0 173 (49) 1.2 205 (62) 1.7
"Smoking Related" 47 (9) 0.8 84 (15) 0.8 41 (56) 1.7 79 (59) 1.5
Not "Smoking Related" 144 (13) 1.3 143 (20) 1.1 132 (46) 1.1 126 (64) 1.8
Lip, Oral Cavity, and
Pharynx 0 - - 17 (12) 0.6 0 - - 17 (53) 1.1
Digestive System 13 (8) 0.7 18 (11) 0.6 12 (50) 1.3 18 (67) 1.7
Respiratory System 4 (25) 2.9 18 (11) 0.6 4 (50) 1.3 18 (50) 1.0
Lung 1 (0) 0.0 14 (14) 0.7 1 (100) 12 (58) 1.4
Bone, Skin, and Connective
Tissue 19 (1 1) 1.0 17 (6) 0.3 20 (30) 0.6 14 (36) 0.6
Breastl 29 (10) 0.9 24 (21) 0.9 28 (43) 0.9 23 (61) 1.4
Female Genital TractlI 72 (11) 1.0 61 (25) 1.2 59 (51) 1.3 54 (70) 2.2
CervixlI 40 (8) 0.7 40 (23) 1.3 34 (56) 1.7 36 (67) 2.0
Eye, Brain and Other
Nervous System 17 (6) 0.5 20 (15) 0.8 15 (53) 1.5 15 (73) 2.8
Brain 11 (9) 0.9 20 (15) 0.8 9 (56) 1.7 15 (73) 2.8
Endocrine Glands 11 (18) 1.9 10 (20) 1.1 11 (55) 1.6 9 (56) 1.3
Hematopoietic Tissue 19 (21) 2.3 22 (41) 3.1 17 (65) 2.4 20 (70) 2.4
tSites with 15 or more cases.
*For comparison, 11% of 220 nonsmoking controls and 18% of 235 smoking controls exposed to mother's smoking.
§For comparison, 43% of 211 nonsmoking controls and 50% of 227 smoking controls exposed to father's smoking.
IlSex specific comparison: 45% of nonsmoking controls exposed to father's smoking and 11% exposed to mother's smoking; 52% of smoking controls exposed to father's smoking and 22%
exposed to mother's smoking.
small increase in risk associated with maternal smoking.
Increased risk associated with father's smoking did not
appear to be explained by differences in such factors as age,
race, sex, social class (as measured by education and
occupation), or smoking habits of the case or control. The
effect was not limited to known smoking related sites.
Estimated relative risks associated with father's smoking
tended to be greater for smokers, males, and non-Whites.
We have previously reported an increased cancer risk for
individuals married to smokers,29 but the apparent effect of
paternal smoking is not altered by adjustment for smoking by
spouse.
Several findings from different sources support the
plausibility of increased cancer risk from early life exposure
to cigarette smoke. In addition to the experimental studiesl-9
and biochemical studies in humans,'0-2' limited support for
the results of the present study can be found in other
epidemiologic studies.22-24'27 Only one of these studies,
however, has reported on cancer risk during adulthood from
exposure to parent's cigarette smoke.27
Stewart, et al, in a large case-control study, found a
very small (RR = 1.1) increased risk for cancer in children
up to age 10 whose mothers smoked.34 An increased cancer
risk related to father's smoking was not seen (RR = 1.0), but
10 years may have been too soon to detect an effect. Neutel
and Buck22 found an increased risk (RR = 1.3) in a prospec-
tive study of cancer risk through age 10 among children
whose mothers smoked during pregnancy, but did not report
on father's smoking.
Questions on parental smoking during pregnancy have
been included in a number of case-control studies of particu-
lar childhood tumors. Our finding of a two-fold increase in
risk for brain cancer among individuals whose fathers
smoked is consistent with the data of Preston-Martin, et al.23
In their study, which focused on exposure to nitrosamines,
an increased risk of brain cancer (RR = 1.5) among children
whose fathers smoked during the mother's pregnancy was
seen. Sidestream cigarette smoke which is passively inhaled
is one source of exposure to nitrosamines and other N-
nitroso compounds.28 Gold, et al, did not report on father's
smoking but found a five-fold increase in risk for brain
tumors among children whose mothers continued to smoke
in pregnancy.35
Findings from a study by Grufferman, et al,24 are
consistent with our finding of a predominantly paternal
effect. In that study, an elevated relative risk for rhabdomyo-
sarcoma was associated only with father's smoking. Man-
ning and Carroll reported no increased risk for childhood
leukemia related to mother's smoking.25 Father's smoking
was not reported. Although the number of cases was small
and dose-response data were inconsistent, Neutel and Buck
did find that the offspring of smoking women had nearly
twice the leukemia risk of offspring of women who did not
smoke. 22
Despite the small number of lung cancer cases included,
we chose to look at lung cancer risk in relation to paternal
smoking because of continued interest in passive smoking
and cancer risk at this site.27'36'37 The RR for lung cancer
among individuals whose fathers smoked was 2.5 after
adjusting for age and individual smoking. The adjusted RR
associated with mother's smoking was 1.8, but this was
based on only two smoking mothers among 15 cases. Correa,
et al, reported an RR of 1.7 for lung cancer associated with
mother's smoking, but no increased risk related to father's
smoking.27
Our finding of a possible cervical cancer risk related to
father's smoking has not been reported elsewhere. There is,
however, growing support for a role of passive smoking (as
measured by spouse smoking) in cervical cancer risk.38 39
Data on parental smoking were obtained retrospectively
from offspring who may not be in a position to provide
accurate histories. Parents or siblings of study subjects were
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also interviewed regarding the smoking histories of the
parents to validate the data obtained from subjects. We
interviewed 649 relatives of subjects included in this report.
Of these, 55 per cent were mothers and 40 per cent were
siblings. For more than 350 subject-mother pairs, agreement
on qualitative smoking questions ranged from 93 to 98 per
cent and was substantially better than chance. There was
also good agreement between subjects and their siblings.
Our findings are not due to any obvious recall bias. The
hypothesis that parental smoking may cause cancer is not
generally well known and study subjects and interviewers
were told only that we were interested in smoking patterns in
families. We obtained similar responses from mothers and
subjects, regardless of case status, suggesting that differen-
tial recall probably did not occur.
It is difficult to distinguish transplacental and passive
childhood exposures in an epidemiologic study: women who
smoke during pregnancy generally continue smoking after
the baby is born.40 Father's smoking may produce transpla-
cental as well as passive childhood exposure.'3,16,20 An effect
of father's smoking on genetic material in sperm is also a
possibility.41-45 Only 16 per cent of the smoking mothers in our
study began smoking after pregnancy, and no mothers smoked
only during pregnancy. This made it difficult to compare
cancer risks for individuals exposed in utero with risk in
individuals exposed only passively in childhood. Further-
more, 94 per cent of the smoking fathers smoked both before
and after the subject's birth.
Nevertheless, if an increased risk were seen for moth-
er's but not father's smoking, a transplacental effect might
be a reasonable explanation. In this study and others,23 24
increased risks were generally related to father's smoking
only. Little increased risk was associated with mother's
smoking, suggesting a passive rather than a transplacental
mechanism. Our failure to find a similar effect for mother's
smoking might be due to the fact that they smoked fewer
cigarettes than fathers or smoked different types of ciga-
rettes. Although children may spend more time with their
mothers than with their fathers, it is also conceivable that
mothers do not smoke when actively engaged in child care
activities.
The increasing frequency of women smoking after the
1920s should provide future studies with increasing power to
detect any late effects of maternal smoking on offspring. The
first sizable cohort of individuals exposed to maternal smok-
ing is only beginning to reach the age at which cancer most
commonly occurs.
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I Mortality Rates in Boston (and Other Large Cities), 1911
Boston's death rate for 1911 was 17.1, which is high compared with rates of most other large
American cities.
The 1911 rates for the other cities having over 500,000 inhabitants were-Cleveland 13.55;
Pittsburgh 14.94; Chicago 14.55; New York 15.22; St. Louis 15.36; Philadelphia 16.51; and Baltimore
18.43.
A brief analysis of these rates is desirable.
Typhoid Fever:-From typhoid Boston had the lowest rate of all the cities. The rates per 100,000
were as follows:-Boston 9.14; Chicago 10.78; New York 10.99; Philadelphia 14.11; Cleveland 14.46;
St. Louis 15.56; Pittsburgh 25.81; and Baltimore 27.28.
Scarlet Fever:-The rates were Baltimore 7.79; Pittsburgh 9.95; Boston 10.74; Philadelphia 11.33;
New York 13.25; Chicago 21.20; St. Louis 27.26; and Cleveland 31.12.
Diphtheria:-The rates were Baltimore 12.05; St. Louis 16.84; Boston 18.00; Cleveland 21.94;
Pittsburgh 23.60; New York 25.84; Philadelphia 31.51; and Chicago 39.11.
Measles:-The rates were Chicago 5.75; Cleveland 6.63; Pittsburgh 9.59; Boston 10.74; New York
13.25; Baltimore 13.63; St. Louis 15.84; and Philadelphia 19.30.
Whooping Cough:-The rates were Chicago 2.45; St. Louis 4.57; Philadelphia 7.34; New York
7.75; Baltimore 8.50; Cleveland 14.80; Boston 15.68; and Pittsburgh 19.54.
Taking all these diseases together, Boston had the lowest rate with 64.30 per 100,000; the others in
order were Baltimore 69.25; New York 70.88; Chicago 7.29; St. Louis 80.07; Philadelphia 83.59;
Pittsburgh 88.49; and Cleveland 88.95.
Tuberculosis of the Lungs:-The rates per 100,000 were Cleveland 121.77; Pittsburgh 130.88; St.
Louis 135.29; Boston 154.88; Chicago 165.98; New York 177.39; Philadelphia 187.31; and Baltimore
205.12.
This analysis ofthe communicable diseases should be extremely gratifying to the people ofBoston.
However, it fails to reveal the reason ofBoston's higher rate. But a study of the figures for 1910, for
which year more complete figures are available, will show much more....
Cancer, cerebral hemorrhage, organic diseases of the heart, pneumonia and violent deaths stand
out as the principal causes which have comparatively high rates in Boston....
There are two reasons why Boston has such a large number ofdeaths ofnon-residents. First it has
a population in its immediate suburbs greater than the population of the city itself. These people labor
in Boston and when ill come to Boston hospitals. The other reason is that Boston is the recognized
medical centre for all New England and attracts those afflicted with cancer, for example, a disease
more prevalent in the New England States than in any of the other registration states.
Moreover in 1910 Boston had a larger percentage of its deaths over 6 years ofage than any of the
cities under consideration. In a word, Boston is an old city and has many old people....
But in a word it may be safely said that Boston's high rate is largely due to its geographical
position in the centre ofpopulous suburbs, and to itsfame as a medical centre, and not, as has been so
often intimated, to the unhealthful conditions in the city.
-Davis WH: Boston's death rate. Am J Public Health 1912; 2:638-640.
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